Steerable Laser Interstitial Thermotherapy (SLIT) Robot for Brain Tumor Therapy
Project Number5R21EB033896-02
Contact PI/Project LeaderSHENG, JUN
Awardee OrganizationUNIVERSITY OF CALIFORNIA RIVERSIDE
Description
Abstract Text
Project Summary/Abstract
Glioblastoma (GBM) is one of the most prevalent and challenging cancers to cure. Each year, nearly 12,000 new
cases of GBM are diagnosed in the US, with the overall median survival being only 12 to 18 months. GBM rarely
metastasizes to other organs; however, there is no effective treatment for GBM tumors. Standard therapies with
surgery combined with adjuvant radiation and FDA-approved drugs can add a few months to median survival
but cannot prevent the recurrence of GBM. For recurrent GBM (rGBM), prognosis is even more dismal. Repeated
surgery is often not recommended since patients have already gone through it during the treatment of initial
GBM, and the efficacy of other treatment options is very limited. Laser interstitial thermotherapy (LITT) is an
emerging technique for minimally invasive treatment of rGBM. By introducing a slender laser probe into a brain
tumor, LITT can ablate the tumor tissue percutaneously using laser radiation. However, existing LITT devices
which often set the tip of a laser probe at the core of the tumor are inadequate to achieve conformal ablation (i.e.,
ablation with the maximum tumor coverage and minimum collateral damage), especially when tumors are large,
irregularly shaped, or multifocal. Hence, to achieve conformal ablation and improve the efficacy of LITT, we
propose a novel robot to deliver thermal radiation at multiple locations inside a brain tumor. We will develop a
novel steerable laser interstitial thermotherapy (SLIT) robot with a slender footprint and a custom-
designed flexible laser ablation probe. We will introduce SLIT to the peripheral of a brain tumor through a small
burr hole, manipulate SLIT around critical structures, and perform ablation at targets that are planned by
clinicians under the guidance of magnetic resonance imaging (MRI). All aspects of new procedure will be
remotely monitored and controlled by clinicians using intra-operative MRI and thermometry (MRT) to ensure
precision and safety. In this project, we will 1) Design and develop an MR-compatible steerable robot with a
flexible ablation probe, 2) Develop software that enables planning and control of multi-site tumor ablation, and
3) Evaluate the safety and functionality of SLIT using clinically relevant models. We have formed a
multidisciplinary team with expertise in minimally invasive surgical robots, biomedical fiber lasers,
neurosurgery, neurosurgical devices, neuropathology, advanced MR imaging, animal models, and
neuroradiology to successfully conduct the proposed studies. LITT for rGBM therapy will serve as a model for
technology development, while the outcome will generate a transformative platform with applications to many
neurosurgical procedures that require dexterous minimally invasive access to brain lesions.
Public Health Relevance Statement
Project Narrative
Laser interstitial thermotherapy (LITT) is an emerging minimally invasive technique for treatment of
glioblastoma (rGBM), which is a common primary brain tumor associated with an extremely dismal prognosis.
However, existing LITT devices can only ablate tissue around the tip of a fixed laser probe and are thus
inadequate for large, irregularly shaped, and multifocal tumors. To achieve conformal tumor ablation, this
project proposes a steerable laser interstitial thermotherapy (SLIT) robot that can navigate a brain tumor along
multiple trajectories and ablate tumor tissue at multiple locations under intra-operative MR guidance.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
627797426
UEI
MR5QC5FCAVH5
Project Start Date
01-September-2023
Project End Date
31-August-2026
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$164,155
Direct Costs
$116,803
Indirect Costs
$47,352
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$164,155
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21EB033896-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21EB033896-02
Patents
No Patents information available for 5R21EB033896-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21EB033896-02
Clinical Studies
No Clinical Studies information available for 5R21EB033896-02
News and More
Related News Releases
No news release information available for 5R21EB033896-02
History
No Historical information available for 5R21EB033896-02
Similar Projects
No Similar Projects information available for 5R21EB033896-02